Assessment and Localisation of Response to Primary Systemic Therapy in Breast Cancer

被引：1
|
作者：
Noble, Frith [1 ]
机构：
[1] Wishaw Gen Hosp, Radiol Dept, 50 Netherton St, Wishaw ML2 0DP, Scotland
来源：
ULTRASOUND | 2009年 / 17卷 / 02期
关键词：
Primary Systemic Therapy; Ultrasound Guided Marking;
D O I：
10.1179/174313409X415819
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary systemic therapy (PST) is used in non-metastatic breast cancer to decrease tumour size and reduce the extent of surgery. This article reviews imaging and surgical issues associated with the increasing use of PST in the management of breast cancer. The role of imaging, with a special focus on ultrasound, is evaluated.
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [21] An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
    H E Lee
    J H Kim
    Y J Kim
    S Y Choi
    S-W Kim
    E Kang
    I Y Chung
    I A Kim
    E J Kim
    Y Choi
    H S Ryu
    S Y Park
    British Journal of Cancer, 2011, 104 : 1730 - 1738
  • [22] Primary systemic therapy (PST) of locally advanced breast cancer using doxorubicin/docetaxel combination
    Dank, M
    Zergenyi, E
    Domotori, Z
    Lahm, E
    Kulka, J
    ANTICANCER RESEARCH, 2003, 23 (3C) : 2879 - 2880
  • [23] An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
    Lee, H. E.
    Kim, J. H.
    Kim, Y. J.
    Choi, S. Y.
    Kim, S-W
    Kang, E.
    Chung, I. Y.
    Kim, I. A.
    Kim, E. J.
    Choi, Y.
    Ryu, H. S.
    Park, S. Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1730 - 1738
  • [24] Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer
    Tímea Tőkés
    Kornélia Kajáry
    Gyöngyvér Szentmártoni
    Zsolt Lengyel
    Tamás Györke
    László Torgyík
    Krisztián Somlai
    Anna-Mária Tőkés
    Janina Kulka
    Magdolna Dank
    Breast Cancer, 2017, 24 : 137 - 146
  • [25] Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
    A N Seo
    H J Lee
    E J Kim
    H J Kim
    M H Jang
    H E Lee
    Y J Kim
    J H Kim
    S Y Park
    British Journal of Cancer, 2013, 109 : 2705 - 2713
  • [26] Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer
    Tokes, Timea
    Kajary, Kornelia
    Szentmartoni, Gyongyver
    Lengyel, Zsolt
    Gyorke, Tamas
    Torgyik, Laszlo
    Somlai, Krisztian
    Tokes, Anna-Maria
    Kulka, Janina
    Dank, Magdolna
    BREAST CANCER, 2017, 24 (01) : 137 - 146
  • [27] Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy
    Sola, Montserrat
    Margeli, Mireia
    Castella, Eva
    Cirauqui, Beatriz
    Mariscal, Antonio
    Rull, Miquel
    Julian, Juan F.
    Luna, Miquel
    Vallejo, Virginia
    Fraile, Manuel
    BREAST, 2013, 22 (05) : 908 - 913
  • [28] Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
    Seo, A. N.
    Lee, H. J.
    Kim, E. J.
    Kim, H. J.
    Jang, M. H.
    Lee, H. E.
    Kim, Y. J.
    Kim, J. H.
    Park, S. Y.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2705 - 2713
  • [29] Patterns of Regression in Breast Cancer after Primary Systemic Treatment
    Zombori, Tamas
    Cserni, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 1153 - 1161
  • [30] Surgery after primary systemic chemotherapy in patients with breast cancer
    Eiermann, Wolfgang
    Ataseven, Beyhan
    BREAST CARE, 2006, 1 (06) : 358 - 361
12345